Xeroderma Pigmentosum

• CLINICAL_TRIALS trial_result · 2026-04-22
  Clinical Trial Update: Examination of Clinical and Laboratory Abnormalities in Patients With Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy

  Clinical trial update describing clinical and laboratory abnormalities in patients with defective DNA repair due to Xeroderma Pigmentosum, C…

• CLINICAL_TRIALS research · 2025-09-19
  Clinical Trial Update: Natural History Study for DNA Repair Disorders

  The University of Minnesota is conducting a natural history study for DNA repair disorders, including Cockayne syndrome, Xeroderma pigmentos…

• CLINICAL_TRIALS withdrawal · 2025-09-10
  Clinical Trial Update: Testing the Combination of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) in Children, Adolescent, and Young Adult Patients With Relapsed/Refractory Cancers That Have an Increased Number of Genetic Changes, The 3CI Study [Phase 1]

  This document reports the withdrawal of a Phase 1 trial evaluating the combination of nivolumab and ipilimumab in pediatric and young adult …

• CLINICAL_TRIALS trial_result · 2025-05-18
  Clinical Trial Update: Reproductive Options in Inherited Skin Diseases

  A clinical trial update indicates a study on reproductive options for inherited skin diseases is ongoing at Maastricht University Medical Ce…

• CLINICAL_TRIALS trial_result · 2024-10-24
  Clinical Trial Update: Trial Assessing the Impact on Facial Skin Quality, Hydration, and Skin Barrier of Three (3) Hydrafacial Treatments in Adults of All Skin Types. [Phase 4]

  Phase 4 clinical trial assessing the impact of three Hydrafacial treatments on facial skin quality, hydration, and barrier function in adult…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2023-09-21
  Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Xeroderma Pigmentosum C and V [Phase 2]

  A Phase 2 clinical trial evaluating the safety and efficacy of afamelanotide in patients with Xeroderma Pigmentosum (XP) type C and V is rep…

• CLINICAL_TRIALS trial_result · 2023-06-18
  Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Xeroderma Pigmentosum (XP) [Phase 2]

  Phase 2 clinical trial evaluating safety and efficacy of afamelanotide in patients with Xeroderma Pigmentosum is ongoing with unknown status…

• CLINICAL_TRIALS trial_result · 2013-11-06
  Clinical Trial Update: T4N5 Liposome Lotion Compared With Placebo Lotion for Preventing Actinic Keratoses in Patients With Xeroderma Pigmentosum [Phase 3]

  Phase 3 trial comparing T4N5 liposome lotion to placebo to prevent actinic keratoses in patients with xeroderma pigmentosum.

• CLINICAL_TRIALS trial_result · 2010-05-14
  Clinical Trial Update: Xeroderma Pigmentosum Patient Experiences

  An update on a Xeroderma Pigmentosum patient’s experiences in an ongoing trial, with the trial status listed as unknown.

• CLINICAL_TRIALS trial_result · 2009-09-30
  Clinical Trial Update: Use of an SPF30 Sunscreen and an After-sun-lotion in Skin Cancer Risk Patients

  A completed clinical trial evaluating SPF30 sunscreen and an after-sun lotion in individuals at risk for skin cancer, including those with X…